QAV S05E03 – Frogger

Talking about the current market volatility, and whether or not we should wait it out and go to cash; we discuss recent articles talking about “investing” in tech stocks and crypto; deep dive on RIO; explain how the Bank Bill Swap Rate works; whether or not new investors should wait until the end of reporting season; getting back to the ‘Buy Follows Sell’ rule and how it applies to CBA; possible reasons why KRM has gone up and MQG has gone down; and the challenges in placing orders at market value.

QAV S05E00 – The Cleansing

In our first episode for 2022, we’re talking about my confusion over some recent 3PTL rule changes, platinum being a buy again, what a “cleansing prospectus” is, Gary’s stellar results, some changes to the buy list, a pulled pork on CIA, CAA and aluminium, Nufarm’s cash flow, how to treat companies we’ve sold using R1, why we use operating cash flow instead of free cash flow, and whether or not CDD is a sell.

QAV S04E52 – Best Of 2021

It’s time for our last show of the year and my annual tradition of trying to pick some highlights from the last 12 months. This year I’m mostly focusing on the journey we went through with iron ore. Back in January 2021 we were talking about FMG and the stellar run it had been on, and why we weren’t going to rush into selling it, particularly when it had a very low sell line. But as the year progress, Tony started to talk more and more about watching the iron ore commodity price which, even though the CEO of FMG assured us would stay strong for a long time, started to slide in the second half of the year, prompting Tony to make some painful decisions….

QAV S04E01 – The Fudge Slope

In our first episode of 2021, we review our portfolio’s CY20 performance; margin loan rates; What TK does on a daily/weekly basis for managing his portfolio; relative QAV performance of large vs mid vs small cap companies; the ‘minimum’ amount of stock someone just getting started should buy; fudging ECX and VUK; whether or not we should rebalance every so often; Tony’s views on CSL; the recent drop in the prices of some gold miners; understanding the formula in column BK of the master checklist; why companies can have a quality score of >100%; and Stock Doctor problems regarding reporting of director holdings.